Fermenta Biotech secures CEP from EDQM for Vitadee 100 SD

30 Jul 2025 Evaluate

Fermenta Biotech has received the Certificate of Suitability (CEP) from European Directorate for the Quality of Medicines & Healthcare (EDQM) for its Spray?Dried variant, Vitadee 100 SD - Cholecalciferol Concentrate (powder form) 100, 000 IU/g being manufactured at its Kullu, Himanchal Pradesh facility.

Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin?D3. The approval underscores Fermenta’s adherence to the stringent European Pharmacopoeial Standards for manufacturing and product quality.  This recognition further enhances Fermenta’s international footprint and its capability to deliver products that meet the highest global quality and regulatory standards. It represents another step forward in company’s mission to expand its global presence and create meaningful impact across the health and nutrition industry. 

Fermenta Biotech possesses a growing portfolio of nutrition including customized Premixes, Fortified Rice Kernel (FRK) and other nutritional ingredients. Apart from its nutrition portfolio, the company is one of the world’s leading manufacturers of Vitamin D3.

Fermenta Biotech Share Price

338.50 5.30 (1.59%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×